Literature DB >> 10736375

Compartmentation of brain glutamate metabolism in neurons and glia.

Y Daikhin1, M Yudkoff.   

Abstract

Intrasynaptic [glutamate] must be kept low in order to maximize the signal-to-noise ratio after the release of transmitter glutamate. This is accomplished by rapid uptake of glutamate into astrocytes, which convert glutamate into glutamine. The latter then is released to neurons, which, via mitochondrial glutaminase, form the glutamate that is used for neurotransmission. This pattern of metabolic compartmentation is the "glutamate-glutamine cycle." This model is subject to the following two important qualifications: 1) brain avidly oxidizes glutamate via aspartate aminotransferase; and 2) because almost no glutamate crosses from blood to brain, it must be synthesized in the central nervous system (CNS). The primary source of glutamate carbon is glucose, and a major source of glutamate nitrogen is the branched-chain amino acids, which are transported rapidly into the CNS. This arrangement accomplishes the following: 1) maintenance of low external [glutamate], thereby maximizing signal-to-noise ratio upon depolarization; 2) the replenishing of the neuronal glutamate pool; 3) the "trafficking" of glutamate through the extracellular fluid in a nonneuroactive form (glutamine); 4) the importation of amino groups from blood, thus maintaining brain nitrogen homeostasis; and 5) the oxidation of glutamate/glutamine, a process that confers an additional level of control in terms of the regulation of brain glutamate, aspartate and gamma-aminobutyric acid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10736375     DOI: 10.1093/jn/130.4.1026S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  90 in total

1.  Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons.

Authors:  Maria G A Hägglund; Smitha Sreedharan; Victor C O Nilsson; Jafar H A Shaik; Ingrid M Almkvist; Sofi Bäcklin; Orjan Wrange; Robert Fredriksson
Journal:  J Biol Chem       Date:  2011-04-21       Impact factor: 5.157

Review 2.  Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.

Authors:  Milan Holecek
Journal:  Metab Brain Dis       Date:  2013-08-31       Impact factor: 3.584

3.  Methodology of H NMR Spectroscopy of the Human Brain at Very High Magnetic Fields.

Authors:  I Tkáč; R Gruetter
Journal:  Appl Magn Reson       Date:  2005-03       Impact factor: 0.831

Review 4.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

5.  Disruption of astrocytic glutamine turnover by manganese is mediated by the protein kinase C pathway.

Authors:  Marta Sidoryk-Wegrzynowicz; Eunsook Lee; Ni Mingwei; Michael Aschner
Journal:  Glia       Date:  2011-08-02       Impact factor: 7.452

Review 6.  Chemotherapy-induced peripheral neuropathy: clinical features, diagnosis, prevention and treatment strategies.

Authors:  Gerardo Gutiérrez-Gutiérrez; María Sereno; Ambrosio Miralles; Enrique Casado-Sáenz; Eduardo Gutiérrez-Rivas
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

7.  Evaluating the Toxicity of the Analgesic Glutaminase Inhibitor 6-Diazo-5-Oxo-L-Norleucine in vitro and on Rat Dermal Skin Fibroblasts.

Authors:  Heith A Crosby; Michael Ihnat; Kenneth E Miller
Journal:  MOJ Toxicol       Date:  2015-03-25

8.  Time-dependent expression of SNAT2 mRNA in the contused skeletal muscle of rats: a possible marker for wound age estimation.

Authors:  Qiu-xiang Du; Jun-hong Sun; Ling-yu Zhang; Xin-hua Liang; Xiang-jie Guo; Cai-rong Gao; Ying-yuan Wang
Journal:  Forensic Sci Med Pathol       Date:  2013-09-18       Impact factor: 2.007

Review 9.  Interactions in the Metabolism of Glutamate and the Branched-Chain Amino Acids and Ketoacids in the CNS.

Authors:  Marc Yudkoff
Journal:  Neurochem Res       Date:  2016-10-01       Impact factor: 3.996

10.  Effects of a monocarboxylate transport 1 inhibitor, AZD3965, on retinal and visual function in the rat.

Authors:  Annette E Allen; Elizabeth A Martin; Katherine Greenwood; Claire Grant; Peter Vince; Robert J Lucas; William S Redfern
Journal:  Br J Pharmacol       Date:  2020-09-13       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.